fbpx

Day: May 14, 2020

[Marketing Medium] Live Event with MEP Svenja Hahn

MEP Svenja Hahn says: “Artificial Intelligence plays an increasing role in our everyday lives. AI technology has a vast potential for innovation and progress, from the use of screening systems in the health sector to self-driving vehicles. I am convinced that these new technologies will offer benefits to European businesses and consumers alike. As lawmakers in the European Parliament, our task is to close loopholes in the current European legislation and respond to legal challenges that might arise with AI applications. Only when the legal framework is fit for the digital age, we can tap the full potential of AI for citizens and the EU’s Digital Single Market. In this regard, it is of utmost importance not to over-regulate, to avoid red tape, and to provide for legal certainty for businesses, investors, and consumers.”

source http://meltwater.pressify.io/publication/5ebd64a21abdb9000474ae71/5aa837df2542970e001981f6

[Marketing Medium] Live Event with MEP Svenja Hahn

MEP Svenja Hahn says: “Artificial Intelligence plays an increasing role in our everyday lives. AI technology has a vast potential for innovation and progress, from the use of screening systems in the health sector to self-driving vehicles. I am convinced that these new technologies will offer benefits to European businesses and consumers alike. As lawmakers in the European Parliament, our task is to close loopholes in the current European legislation and respond to legal challenges that might arise with AI applications. Only when the legal framework is fit for the digital age, we can tap the full potential of AI for citizens and the EU’s Digital Single Market. In this regard, it is of utmost importance not to over-regulate, to avoid red tape, and to provide for legal certainty for businesses, investors, and consumers.”

from Consumer Choice Center https://ift.tt/2zCMJsR

Liberar entrega de maconha no Canadá pós-pandemia ajudará a combater o comércio ilegal

Tornar a entrega de Cannabis permanente e não temporária seria um grande passo em frente para o mercado jurídico.

Uma das maiores críticas à legalização canadense da Cannabis é que suas regras complicadas e opções limitadas de varejo não podem competir com o mercado clandestino. O que ajudaria? Permitir que as entregas de Cannabis aos varejistas continuem após a pandemia.

Também melhoraria bastante o sistema de entrega monopolizado que existia antes do Covid-19 afrouxar alguns regulamentos de distribuição. Por exemplo, antes da pandemia, a Ontario Cannabis Store (OCS) era incapaz de fazer a entrega no mesmo dia via Canada Post . Quando o OCS tentou oferecer a entrega no mesmo dia contratando um serviço de terceiros, o varejista on-line provincial só poderia oferecê-lo para selecionar áreas e logo interrompeu a opção por causa da alta demanda.

A medida temporária que permite o recolhimento na calçada e a entrega em domicílio pelos varejistas não é perfeita e como em qualquer política do governo, o percalço está nos detalhes.

Por um lado, há uma disposição de que o entregador deve ser um funcionário do varejista. Essa é uma restrição desnecessária que limita significativamente a expansão. Os varejistas não estão equipados com capital nem conhecimento para operar uma frota de veículos. Isto se destaca quando a demanda aumenta. Eles devem ser capazes de contratar esse serviço como qualquer outra empresa.

Em segundo lugar, o governo Ford deve permitir que serviços de terceiros sejam usados por revendedores licenciados, sem a necessidade de uma licença para essa função. Tudo o que Ontário precisa fazer é seguir o exemplo de Manitoba, que permite isso. Fazer essa alteração oferecerá benefício ao consumidor, permitindo que empresas de serviços de tecnologia entrem no mercado, dando aos varejistas legais uma vantagem sobre o mercado ilegal.

Eliminar a necessidade de funcionários e permitir que empresas de tecnologia não licenciadas atendam às lojas expande as opções que os varejistas têm para levar produtos aos clientes. Eles poderiam terceirizar completamente sua entrega por meio de terceiros com uma licença de entrega de maconha ou trabalhar com outros aplicativos de entrega, como os restaurantes.

A província pode exigir que os motoristas não licenciados tenham seu certificado CannSell, que é semelhante ao Smart Serve para álcool. O CannSell custa US$ 64,99 e forneceria aos motoristas o conhecimento necessário para detectar deficiências e proteger o acesso a menores.

Para a implantação, a província poderá legalizar esse tipo de entrega amanhã e conceder aos motoristas um período de carência de 30 dias para concluir o CannSell. Quando a província anunciou que os restaurantes podiam entregar álcool com pedidos de comida, eles fizeram exatamente isso, dando aos motoristas de entrega de comida um mês para obter o Certificado de Serviço Inteligente.

Tornar a entrega de Cannabis permanente e não temporária seria um grande passo em frente para o mercado jurídico em Ontário. Isso beneficiaria significativamente os varejistas. Mais importante, porém, beneficiaria os consumidores ao expandir e aprimorar suas opções.


The Consumer Choice Center is the consumer advocacy group supporting lifestyle freedom, innovation, privacy, science, and consumer choice. The main policy areas we focus on are digital, mobility, lifestyle & consumer goods, and health & science.

The CCC represents consumers in over 100 countries across the globe. We closely monitor regulatory trends in Ottawa, Washington, Brussels, Geneva and other hotspots of regulation and inform and activate consumers to fight for #ConsumerChoice. Learn more at consumerchoicecenter.org

Modern agriculture is actively under threat – we need to save it

Mycotoxins represent an active and palpable threat to the health of consumers, with millions affected particularly in developing nations. The open hostility towards certain crop protection measures has emphasised this problem, as fungicides are coming under fire. The scientific method and consumer health should be the metrics of public agricultural policy.

We’ve come a long way from how our ancestors produced and prepared food.

Mechanisation, agricultural intensification, synthetic fertilisers, and even drones are now part of modern farming. This allows us to feed billions on a daily basis.

But with the emergence of the mass-production of food came its opponents, often environmentalists unhappy with resource use, animal use, or consumerism. Picture traveling back in time and explaining to people that there will be a world in which average people can actually afford fresh vegetables and refrigerated meat, which is available at all times but there are simultaneously people who oppose this immense progress and want to deprive others of its wonders.

There is nothing inherently wrong with being nostalgic. Even today, there are farming initiatives that promote and practice “peasant farming”, and live off their own production in a commune. No harm done, the world economy and developing nations will remain untouched by this first-world luxury.

That said, environmentalists have gone far beyond the realm of romanticising the old days: they have set their eyes on implementing it by force, if necessary through distorting reality.

A vast network of organisations, including known players such as Greenpeace, are throwing a myriad of unscientific publications at the wall in different European countries, in the attempt to find out what sticks. Their latest target is fungicides.

Fungicides are used to fight fungus spores, which if carried from the outside of the plant to their inside, are dangerous to human health. These molds produce mycotoxins, which are toxic metabolites.

Mycotoxins are divided into subcategories, namely aflatoxins, ochratoxin A (OTA), fumonisins (FUM), zearalenone (ZEN), and deoxynivalenol (DON – also known as vomitoxin), which can all be ingested through eating contaminated food, including dairy products (as infected animals can carry it into milk, eggs, or meat).

The most dangerous kinds are aflatoxins, which can affect corn, wheat, rice, soybeans, peanuts, and tree nuts, and can cause cancer. Most disconcertingly, up to 28% of all liver cancer can be attributed to aflatoxins, and its immunosuppressant features leave humans weakened against other diseases.

In Africa, this is a deadly epidemic. Aflatoxin exposure is more deadly than exposure to malaria or tuberculosis, with 40% of all liver cancers in Africa being related to it. Mycotoxin contamination can occur through inadequate food storage, but more importantly it occurs in absence of the correct crop protection measures, including chemicals.

As a result of mycotoxins, food products are prevented from entering Europe, and Africa loses millions in unusable food every year.

However, this is not only an issue in Africa. According to 2017 data, Europe is also at severe risk of mycotoxin contamination. A 10-year survey conducted by the BIOMIN research centre in Austria found that approximately 20% of Central European grain feed and almost 12% of Southern Europe’s grain feed exceeded EU regulatory limits.

In 2013, France requested to have its maize samples exempted from EU regulation on mycotoxins, because its harvest would have been largely unusable. The 2018 data showed 6% of field and 15% of French silo maize samples were contaminated with aflatoxins.

The European Union, as well as national food safety authorities, have authorised a dozen of SDHI fungicides, which fight mycotoxins, and have been re-confirmed as safe as recently as last year.

On the other side of the argument, environmentalists rely on the results presented by a handful of French researchers, presented in 2018 in a non-peer reviewed publication by the name of bioRxiv. Their claims: SDHI fungicides can cause rare cancers and neurological impairments, and the current toxicological reports are inaccurate.

The French Authority for Food Safety (ANSES) released a report which debunked those claims. The agency found no basis for the publication’s claims, explaining that SDHIs are rapidly metabolised and eliminated from the body and that despite these fungicides having been on the market for a long time, that no scientific evidence points towards adverse effects to human health or the environment.

Despite attacks on the integrity of ANSES (which had offered both dialogue and publishing all of its SDHI data available for review), these activists have not presented further evidence for their theory. This hasn’t prevented environmentalist groups from demanding the ban of all fungicides, and an extreme pivot to a form of agriculture that shuns any and all biotechnology.

If they prove successful in banning SDHIs in France, these same activists would take their quest to the next level: the European Union. A long battle would ensue over the future of conventional agriculture, and there is no doubt that facts will be distorted and bogus science will rise to the surface.

But we cannot let it go that far. Food security and the health of consumers are at stake. If the argument is that genetic engineering provides cheaper and better ways to fight insects and mycotoxins, then that is a valid scientific argument that ought to be supported.

However, environmentalists have shown little openness to new breeding technologies, and in turn endorse “agroecology”, or peasant farming. Our ancestors would be rightfully horrified at the thought of that happening. We need to make reasoned arguments in favour of the scientific method to prevent that from happening. It’s the only way we can keep the future from becoming the past.

Originally published here.


The Consumer Choice Center is the consumer advocacy group supporting lifestyle freedom, innovation, privacy, science, and consumer choice. The main policy areas we focus on are digital, mobility, lifestyle & consumer goods, and health & science.

The CCC represents consumers in over 100 countries across the globe. We closely monitor regulatory trends in Ottawa, Washington, Brussels, Geneva and other hotspots of regulation and inform and activate consumers to fight for #ConsumerChoice. Learn more at consumerchoicecenter.org

Federal attack on patents will hurt innovation

Hundreds of global pharmaceutical manufacturers have narrowed their sights on a vaccine or cure, which is a considerable undertaking in terms of cost.

By speeding up the approval process for any vaccine or drug intended to treat Covid-19, Health Canada has shown that it can be responsive in this pandemic. But, not every decision the federal government has made has been for the better. Especially when it comes to amending the Patent Act and completely sidestepping the patent process in our country, which will have some serious negative externalities. 

In amending this law, the government has given itself the power to override patents for drugs, vaccines and medical equipment allowing for manufacturers to create generic copies of patented drugs, without having to negotiate or settle with the patent owners. Only after the fact will patent holders be compensated, at a rate unilaterally determined by the government.

While “sticking it” to Big Pharma may sound fashionable, it will actually end up hurting more people in the end. Suspending patents via compulsory licensing runs the risk of seriously hindering the innovation process that creates new drugs in the first place. Medical innovation is needed now, more than ever, under the threat of Covid-19, and we must pursue it at any cost. What regulators fail to see in their move is that innovation and intellectual property are intrinsically linked and people would suffer without them both. 

Hundreds of global pharmaceutical manufacturers have narrowed their sights on a vaccine or cure, which is a considerable undertaking in terms of cost. IP rights are what provide incentives for these manufacturers to create innovative treatments and get a return on their investment to create new drugs. Even modest IP protections ensure that manufacturers recover costs, which allows them to continue the process of heavily investing in research and development. That’s something we should encourage, not erase.

An example of a patented medicine saving the lives of hundreds of thousands, without compulsory licensing, can be seen in the vast expansion and availability of Gilead’s Hepatitis C drug. Under a very extensive partnership campaign, Gilead licenses out their drugs to local partner firms in middle and low-income countries, offering the drugs at-cost. What easily clocks in at $100,000 USD is sold for hundreds to ensure that patients have access – all without upending patents.

Outside of innovation, the federal government’s patent retreat may not even work in the first place. Upending intellectual property rights doesn’t all of a sudden mean that newly permitted manufacturers have the knowledge and resources needed to scale up production. A generic manufacturer, as a result of changes to the Patent Act, may have the formula for a drug, but that doesn’t mean they can simply flip a switch and produce that drug at scale. 

Many of these generic manufacturers will not have the proper supply chain infrastructure needed to produce these drugs, and won’t be able to access the active ingredients needed in the face of growing medical export bans. India, one of the world’s largest producers of ingredients for medicines, has already implemented an export ban for 26 pharmaceutical ingredients and products, further compounding supply chain problems for producers of generics. 

In that sense, suspending patents is a lot like giving producers of generics the blueprints without access to the tools, labour, or raw materials needed to turn a building plan into a finished product.

While it may sound good to suspend patents in a pandemic, it should be recognized that doing so runs the risk of severely hindering both present and future innovation, which are so desperately needed. Added to that, examples like Gilead’s partnerships in middle and low-income countries prove that upending patents isn’t required to ensure drug availability. Rather than shredding intellectual property rights and patents to respond to Covid-19, the Canadian government should focus elsewhere.  Easing the regulatory approval process, fast tracking drugs approved by health regulators in other OECD countries, and eliminating tariffs on medical equipment would have more of an impact. 

We all want medical innovation and for Canadians to have access to the care and drugs they need. Let’s not make it more difficult to achieve that with bad public policy. 

Originally published here.


The Consumer Choice Center is the consumer advocacy group supporting lifestyle freedom, innovation, privacy, science, and consumer choice. The main policy areas we focus on are digital, mobility, lifestyle & consumer goods, and health & science.

The CCC represents consumers in over 100 countries across the globe. We closely monitor regulatory trends in Ottawa, Washington, Brussels, Geneva and other hotspots of regulation and inform and activate consumers to fight for #ConsumerChoice. Learn more at consumerchoicecenter.org

Larangan jualan rokok semasa PKP kukuhkan pasaran gelap

KUALA LUMPUR – Mengehadkan akses kepada tembakau semasa Perintah Kawalan Pergerakan (PKP) telah mendorong kebanyakan pengguna beralih kepada pasaran gelap, menurut kaji selidik.

Ia merupakan dapatan daripada kaji selidik yang dijalankan oleh Populus sebuah firma perunding peneraju di dalam kaji selidik dan strateg dan merupakan penasihat kepada beberapa syarikat terkemuka, badan awam dan jenama di United Kingdom.

Menurut kajian itu, lapan daripada setiap 10 orang dewasa Malaysia (80%) bersetuju bahawa jika penjualan tembakau dilarang semasa tempoh PKP, orang ramai akan melanggar larangan tersebut demi untuk mendapatkan produk itu.

Hampir tiga per empat responden (72%, dan 78% perokok) pula bersetuju orang ramai akan terus membeli produk tembakau, tetapi jualan akan beralih kepada pasaran gelap/haram.

Menurutnya, tidak memeranjatkan apabila kebanyakan rakyat Malaysia (58%) beranggapan larangan tersebut akan menggalakkan orang berhenti merokok.

Namun, lebih ramai lagi (71%) bersetuju bahawa larangan itu meningkatkan penularan koronavirus menerusi penjualan produk haram yang tidak mempunyai piawaian keselamatan di dalam pengedaran.

Fred Roeder, Pengarah Urusan Consumer Choice Center berkata, berdasarkan kajian yang dibuat jelas menunjukkan orang ramai akan terus merokok dan berkemungkinan berusaha lebih lagi untuk mencari bekalan alternatif apabila rokok mereka sudah habis.

Di bawah langkah-langkah PKP, melakukan pergerakan tidak penting meletakkan nyawa di dalam bahaya kerana menambah risiko kontak dan penyebaran Covid-19.

Di Malaysia, semasa PKP, rokok tidak tersenarai sebagai barangan penting dan tidak dibenar untuk diedarkan, sekali gus mengakibatkan lonjakan dalam perdagangan rokok haram, sebagaimana dinyatakan oleh pihak berkuasa berkaitan di dalam laporan-laporan berita terkini.

Consumer Choice Center (CCC) adalah firma yang terlibat dalam melaksanakan kaji selidik awam.

Majoriti besar responden kaji selidik (72%) juga bimbang iaitu memasukkan larangan penjualan tembakau sebagai sebahagian daripada langkah kawalan pergerakan, akan mengalih sumber penting dalam usaha memerangi Covid-19 disebabkan pertambahan kos dan masa penguatkuasaan:

”Inisiatif menggalakkan orang ramai supaya berhenti merokok semasa PKP adalah suatu niat yang murni, ia sebenarnya gagal. Sebaliknya, langkah itu memperkasa sindiket jenayah antara-negara dan fasilitator yang rasuah, sekali gus menguatkan lagi kehadiran rokok haram yang bersifat endemik di Malaysia,’’ tambah Roeder.

Originally published here.


The Consumer Choice Center is the consumer advocacy group supporting lifestyle freedom, innovation, privacy, science, and consumer choice. The main policy areas we focus on are digital, mobility, lifestyle & consumer goods, and health & science.

The CCC represents consumers in over 100 countries across the globe. We closely monitor regulatory trends in Ottawa, Washington, Brussels, Geneva and other hotspots of regulation and inform and activate consumers to fight for #ConsumerChoice. Learn more at consumerchoicecenter.org

Scroll to top
en_USEN